Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
Prediction of disability progression in fingolimod-treated patients.
Immune surveillance and response to JC virus infection and PML.
Advanced techniques using contrast media in neuroimaging.
Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
Biased Homozygous Haplotypes Across the Human Caveolin 1 Upstream Purine Complex in Parkinson's Disease.
A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis.
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
T-cell reactivity against AQP4 in neuromyelitis optica.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720).
Neuromyelitis optica.
Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Transcriptional de-repression of ERVWE1 following influenza A virus infection.
Adaptive Immune Responses in CNS Autoimmune Disease: Mechanisms and Therapeutic Opportunities.
The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.
Natural killer cells and their receptors in multiple sclerosis.
Gender and autoimmune comorbidity in multiple sclerosis.
Preliminary evaluation of variable compliance joystick for people with multiple sclerosis.
Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Expression and localization of aquaporin-4 in sensory ganglia.
Pages
« first
‹ previous
…
372
373
374
375
376
377
378
379
380
…
next ›
last »